24/7 Market News Snapshot 28 March, 2025 – bluebird bio, Inc. Common Stock (NASDAQ:BLUE)

March 28, 2025

DENVER, Colo., 28 March, 2025 (247marketnews.com) – (NASDAQ:BLUE) are discussed in this article.
bluebird bio, Inc. (NASDAQ:BLUE) is currently experiencing a notable increase in stock value, opening at $3.78 and rising approximately 19.66% to trade at $4.535. This upward momentum is reflected in a trading volume of 1.87 million shares, indicating heightened investor interest and potential for continued gains. Technical analysts are advised to observe resistance levels around $4.75 and support near the opening price to gauge the sustainability of this trend amid broader market dynamics.

In a significant development, bluebird bio has received an unsolicited non-binding acquisition proposal from Ayrmid Ltd, offering $4.50 per share in cash, along with a one-time contingent value right of $6.84 per share based on the achievement of defined net sales milestones. This proposal emerges in the context of bluebird’s existing merger agreement with Carlyle and SK Capital Partners, which currently stipulates an acquisition price of $3.00 per share, alongside the same contingent value rights.

The bluebird Board of Directors is undertaking a comprehensive evaluation of the Ayrmid proposal, engaging with both legal and financial advisors to assess its implications. Despite this new offer, the Board has reiterated its support for the Carlyle and SK Capital merger, continuing to explore avenues that prioritize shareholder value while adhering to fiduciary responsibilities.

Notably, bluebird bio has established itself as a frontrunner in gene therapy since its inception in 2010, successfully advancing innovative treatments from clinical trials to FDA approvals within a short timeframe. The company’s focus remains on severe genetic disorders, with a growing portfolio of therapies targeting conditions such as sickle cell disease and cerebral adrenoleukodystrophy. As bluebird navigates these developments, it remains dedicated to its mission of delivering transformative healthcare solutions while ensuring transparency with its stakeholders.

Related news for (BLUE)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.